← Leaderboards
Richard A Cohen
Boston Medical Center
$17,708,073
Attributed
$17,708,073
Total exposure
25
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$17,708,073 · 25
By mechanism
R01$9,924,240 · 5
P01$3,900,428 · 3
R37$2,186,427 · 1
P50$659,928 · 1
M01$447,686 · 1
R21$446,875 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Nitric Oxide”
- Solomon H Snyder · Johns Hopkins University$33,003,131
- Jay Louis Zweier · Ohio State University$27,671,715
- Stuart A Lipton · Burnham Institute For Medical Research$26,301,120
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$24,661,240
- Jonathan S. Stamler · Case Western Reserve University$24,571,968
- William C. Sessa · Yale University$21,022,028
Research focus
Nitric OxideProteinsOxidantsAtherosclerosisMediatingOxidative StressCysteineBlood VesselsOxidation-ReductionPeroxonitriteSulfhydryl CompoundsLabelResponseCellsSignal TransductionEndothelial CellsOxidationEndotheliumOxygenPreventAngiogenesisModificationCell PhysiologyMass Spectrum Analysis
Grant awards (67)
Redox Regulation of p21ras in Angiogenesis$433,561
R37 · FY2014 · HL · contact PI
Redox Regulation of p21ras in Angiogenesis$421,176
R37 · FY2013 · HL · contact PI
Aortic Stiffness and Hypertension in Obese Mice$385,710
R01 · FY2013 · HL · contact PI
Redox Regulation of SERCA by Nitric Oxide$385,710
R01 · FY2013 · HL · contact PI
SIRT1, Polyphenols, and Endothelial Oxidants$285,491
P01 · FY2013 · HL · contact PI
Redox Regulation of p21ras in Angiogenesis$442,408
R37 · FY2012 · HL · contact PI
Aortic Stiffness and Hypertension in Obese Mice$405,158
R01 · FY2012 · HL · contact PI
Redox Regulation of SERCA by Nitric Oxide$404,951
R01 · FY2012 · HL · contact PI
SIRT1, Polyphenols, and Endothelial Oxidants$299,885
P01 · FY2012 · HL · contact PI
Redox Regulation of p21ras in Angiogenesis$442,407
R37 · FY2011 · HL · contact PI
Aortic Stiffness and Hypertension in Obese Mice$408,834
R01 · FY2011 · HL · contact PI
Redox Regulation of SERCA by Nitric Oxide$407,708
R01 · FY2011 · HL · contact PI
SIRT1, Polyphenols, and Endothelial Oxidants$299,885
P01 · FY2011 · HL · contact PI
PTM MAPPING IN HUMAN H-RAS UNDER OXIDATIVE STRESSES$18,464
P41 · FY2011 · RR · contact PI
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$7,688
P41 · FY2011 · RR · contact PI
Redox Regulation of p21ras in Angiogenesis$446,875
R37 · FY2010 · HL · contact PI
Aortic Stiffness and Hypertension in Obese Mice$406,668
R01 · FY2010 · HL · contact PI
Redox Regulation of SERCA by Nitric Oxide$406,250
R01 · FY2010 · HL · contact PI
SIRT1, Polyphenols, and Endothelial Oxidants$401,180
P01 · FY2010 · HL · contact PI
Nitric Oxide in Hemodialysis AV Fistula Maturation$243,750
R21 · FY2010 · DK · contact PI
PTM MAPPING IN HUMAN H-RAS UNDER OXIDATIVE STRESSES$40,472
P41 · FY2010 · RR · contact PI
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$9,312
P41 · FY2010 · RR · contact PI
Insulin resistance, endothelial oxidants and Ras$460,476
P01 · FY2009 · HL · contact PI
SIRT1, Polyphenols, and Endothelial Oxidants$399,202
P01 · FY2009 · HL · contact PI
Angiotensin-induced Oxidants and Vascular Cell Phenotype$301,995
R01 · FY2009 · AG · contact PI
Nitric Oxide in Hemodialysis AV Fistula Maturation$203,125
R21 · FY2009 · DK · contact PI
Angiotensin-induced Oxidants and Vascular Cell Phenotype$19,721
R01 · FY2009 · AG · contact PI
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$9,492
P41 · FY2009 · RR · contact PI
Insulin resistance, endothelial oxidants and Ras$440,211
P01 · FY2008 · HL · contact PI
NO, SERCA, and Oxidative Stress in Atherosclerosis$368,131
R01 · FY2008 · HL · contact PI
Angiotensin-induced Oxidants and Vascular Cell Phenotype$301,995
R01 · FY2008 · AG · contact PI
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$9,074
P41 · FY2008 · RR · contact PI
PROTEIN 3-NY ID METHOD OF AFFINITY LABEL, SOLID PHASE CAPTURE$1,300
P41 · FY2008 · RR · contact PI
Insulin resistance, endothelial oxidants and Ras$439,080
P01 · FY2007 · HL · contact PI
NO, SERCA, and Oxidative Stress in Atherosclerosis$368,131
R01 · FY2007 · HL · contact PI
Angiotensin-induced Oxidants and Vascular Cell Phenotype$308,159
R01 · FY2007 · AG · contact PI
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$15,083
P41 · FY2007 · RR · contact PI
PROTEIN 3-NY ID METHOD OF AFFINITY LABEL, SOLID PHASE CAPTURE$2,155
P41 · FY2007 · RR · contact PI
Insulin resistance, endothelial oxidants and Ras$415,514
P01 · FY2006 · HL · contact PI
NO, SERCA, and Oxidative Stress in Atherosclerosis$375,886
R01 · FY2006 · HL · contact PI
Angiotensin-induced Oxidants and Vascular Cell Phenotype$314,433
R01 · FY2006 · AG · contact PI
PROTEIN 3-NY ID METHOD OF AFFINITY LABEL, SOLID PHASE CAPTURE$4,004
P41 · FY2006 · RR · contact PI
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$3,337
P41 · FY2006 · RR · contact PI
Insulin resistance, endothelial oxidants and Ras$403,750
P01 · FY2005 · HL
NO, SERCA, and Oxidative Stress in Atherosclerosis$384,932
R01 · FY2005 · HL
Angiotensin-induced Oxidants and Vascular Cell Phenotype$322,000
R01 · FY2005 · AG
EFFECTS OF DISRUPTIVE SLEEP ON HORMONAL AND RENAL RESPONSES TO POSTURE$179,514
M01 · FY2005 · RR
PROTEIN 3-NY ID METHOD OF AFFINITY LABEL, SOLID PHASE CAPTURE$3,993
P41 · FY2005 · RR
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$3,328
P41 · FY2005 · RR
NO, SERCA, and Oxidative Stress in Atherosclerosis$400,182
R01 · FY2004 · HL
ANGIOTENSIN II, OXIDATIVE STRESS, AND ATHEROSCLEROSIS$315,000
R01 · FY2004 · HL
Effects of Disruptive sleep on Hormonal /Renal Responses$268,172
M01 · FY2004 · RR
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY$8,250
P41 · FY2004 · RR
PROTEIN 3-NY ID METHOD OF AFFINITY LABEL, SOLID PHASE CAPTURE$6,537
P41 · FY2004 · RR
NO, SERCA AND OXIDATIVE STRESS IN ATHEROSCLEROSIS$328,606
R01 · FY2003 · HL
ANGIOTENSIN II, OXIDATIVE STRESS, AND ATHEROSCLEROSIS$315,000
R01 · FY2003 · HL
Oxidants, eicosanoids, and endothelium in diabetes$402,500
R01 · FY2002 · HL
NO, SERCA AND OXIDATIVE STRESS IN ATHEROSCLEROSIS$321,177
R01 · FY2002 · HL
ANGIOTENSIN II, OXIDATIVE STRESS, AND ATHEROSCLEROSIS$315,000
R01 · FY2002 · HL
G6PD IN OXIDATIVE STRESS ASSOCATED WITH ATHEROSCLEROSIS$219,976
P50 · FY2002 · HL
ANGIOTENSIN II, OXIDATIVE STRESS, AND ATHEROSCLEROSIS$315,000
R01 · FY2001 · HL
NO, SERCA AND OXIDATIVE STRESS IN ATHEROSCLEROSIS$313,965
R01 · FY2001 · HL
G6PD IN OXIDATIVE STRESS ASSOCATED WITH ATHEROSCLEROSIS$219,976
P50 · FY2001 · HL
ANGIOTENSIN II, OXIDATIVE STRESS, AND ATHEROSCLEROSIS$315,000
R01 · FY2000 · HL
NO, SERCA AND OXIDATIVE STRESS IN ATHEROSCLEROSIS$306,438
R01 · FY2000 · HL
G6PD IN OXIDATIVE STRESS ASSOCATED WITH ATHEROSCLEROSIS$219,976
P50 · FY2000 · HL
DIABETES, NITRIC OXIDE AND ATHEROGENESIS$55,754
P01 · FY2000 · HL